Non-invasive assessment of cirrhosis using multiphasic dual-energy CT iodine maps: correlation with model for end-stage liver disease score
Sign Up to like & getrecommendations! Published in 2020 at "Abdominal Radiology"
DOI: 10.1007/s00261-020-02857-0
Abstract: To determine whether multiphasic dualenergy (DE) CT iodine quantitation correlates with the severity of chronic liver disease. We retrospectively included 40 cirrhotic and 28 non-cirrhotic patients who underwent a multiphasic liver protocol DECT. All three… read more here.
Keywords: cirrhotic patients; disease; equilibrium; iodine ... See more keywords
Causes and Management of Non-cirrhotic Portal Hypertension
Sign Up to like & getrecommendations! Published in 2020 at "Current Gastroenterology Reports"
DOI: 10.1007/s11894-020-00792-0
Abstract: Non-cirrhotic portal hypertension (NCPH) includes a heterogeneous group of conditions. The aim of this paper is to make an overview on the denominations, diagnostical features and management of porto-sinusoidal vascular disease (PSVD) and chronic portal… read more here.
Keywords: non cirrhotic; management; portal hypertension; cirrhotic portal ... See more keywords
Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.
Sign Up to like & getrecommendations! Published in 2022 at "Advances in medical sciences"
DOI: 10.1016/j.advms.2022.02.005
Abstract: PURPOSE Portal hypertension (PH)-associated splenomegaly is caused by portal venous congestion and splanchnic hyperemia. This can trigger hypersplenism, which favors the development of cytopenia. We investigated the time-dependent impact of splenectomy on portal pressure and… read more here.
Keywords: non cirrhotic; splenectomy; pressure; ppvl bdl ... See more keywords
Non-Cirrhotic Intrahepatic Portal Hypertension Induced Pulmonary Arterial Hypertension: Is it More Prevalent than we Think?
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cardiac Failure"
DOI: 10.1016/j.cardfail.2019.07.338
Abstract: Introduction Porto-Pulmonary Hypertension (PoPH) belongs to WHO group I, Pulmonary Arterial Hypertension (PAH). It has a prevalence of 0.5-5% and is potentially curable with liver transplant. Non-cirrhotic intrahepatic portal hypertension (NCIPH) is a rare cause… read more here.
Keywords: portal hypertension; pulmonary arterial; hypertension; cirrhotic intrahepatic ... See more keywords
Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.
Sign Up to like & getrecommendations! Published in 2020 at "Clinics and research in hepatology and gastroenterology"
DOI: 10.1016/j.clinre.2020.03.016
Abstract: Chronic non cirrhotic extrahepatic portal vein obstruction (EHPVO) refers to the cavernomatous transformation of the portal vein (the so-called "portal cavernoma") which occurs following acute thrombosis of the portal vein in the absence of recanalization.… read more here.
Keywords: vein; chronic non; portal vein; cirrhotic extrahepatic ... See more keywords
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy
Sign Up to like & getrecommendations! Published in 2020 at "Cellular and Molecular Gastroenterology and Hepatology"
DOI: 10.1016/j.jcmgh.2020.12.009
Abstract: Background & Aims Hepatocellular carcinoma (HCC) arises in a cirrhotic, pro-angiogenic microenvironment. Inhibiting angiogenesis is a key mode of action of multikinase inhibitors and current non-cirrhotic models are unable to predict treatment response. We present… read more here.
Keywords: cirrhotic model; response; multikinase inhibitors; model ... See more keywords
Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?
Sign Up to like & getrecommendations! Published in 2021 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2021.09.029
Abstract: Clinical and experimental advances related to the detection, magnitude and pathobiology of subclinical portal hypertension in nonalcoholic fatty liver disease (NAFLD), primarily observed in the presence of nonalcoholic steatohepatitis (NASH), prompt us to revisit current… read more here.
Keywords: subclinical portal; overlooked subclinical; hypertension non; hypertension ... See more keywords
Clinical utility of brain MRS imaging of patients with adult-onset non-cirrhotic hyperammonemia
Sign Up to like & getrecommendations! Published in 2021 at "Molecular Genetics and Metabolism Reports"
DOI: 10.1016/j.ymgmr.2021.100742
Abstract: Adult-onset non-cirrhotic hyperammonemia (NCH) is a rare, but often fatal condition that can result in both reversible and irreversible neurological defects. Here we present five cases of adult-onset non-cirrhotic hyperammonemia wherein brain magnetic resonance spectroscopy… read more here.
Keywords: adult onset; cirrhotic hyperammonemia; mrs; onset non ... See more keywords
Non cirrhotic portal hypertension secondary to oxaliplatin therapy: Incidence and presentation
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Hepatology"
DOI: 10.1016/s0168-8278(18)31665-9
Abstract: Background: Recently, several studies have identified a possible relationship between the therapy with oxaliplatin and the development of non-cirrhotic portal hypertension. However, the incidence and the way of presentation of the disease in series of… read more here.
Keywords: therapy; oxaliplatin; hypertension; portal hypertension ... See more keywords
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-04991-0
Abstract: Nonalcoholic fatty liver disease (NAFLD) represents an emerging cause of hepatocellular carcinoma (HCC), especially in non-cirrhotic individuals. The rs641738 C > T MBOAT7/TMC4 variant predisposes to progressive NAFLD, but the impact on hepatic carcinogenesis is unknown. In… read more here.
Keywords: hepatocellular carcinoma; hcc; cirrhotic individuals; mboat7 rs641738 ... See more keywords
An integrated analysis of fecal microbiome and metabolomic features distinguish Non-cirrhotic NASH from healthy control populations.
Sign Up to like & getrecommendations! Published in 2023 at "Hepatology"
DOI: 10.1097/hep.0000000000000474
Abstract: There is great interest in identifying microbiome features as reliable noninvasive diagnostic and/or prognostic biomarkers for non-cirrhotic NASH fibrosis. Several cross-sectional studies have reported gut microbiome features associated with advanced NASH fibrosis and cirrhosis, where… read more here.
Keywords: non cirrhotic; microbiome features; cirrhotic nash; nash fibrosis ... See more keywords